Guest Post: How proactivity and planning helped Novartis ensure a stable supply of medicines during COVID-19

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post fromSteffen Lang, Ph.D., Global Head of Novartis Technical Operations to discuss how Novartis has plans in place to help ensure their supply chains remain operational even in unexpected situations like COVID-19.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: PhRMA Member Company Manufacturing Coronavirus Source Type: news